FDA.reportPublic FDA data

NDC 68210-5011 - Maximum Strength Nasal Decongestant

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68210-5011
Package NDCs from labels
68210-5011-7
Manufacturer
Spirit Pharmaceuticals LLC
Effective date
2024-12-13
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Maximum Strength Nasal Decongestant - Spirit Pharmaceuticals LLCSpirit Pharmaceuticals LLC2024-12-13HUMAN OTC DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68210-5011-7Maximum Strength Nasal Decongestant3 in 1 CARTONTABLET, COATED34
68210-5011-7Maximum Strength Nasal Decongestant24 in 1 BLISTER PACKTABLET, COATED244

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68210-5011MAXIMUM STRENGTH NASAL DECONGESTANT (PHENYLEPHRINE HYDROCHLORIDE) TABLET, COATED [SPIRIT PHARMACEUTICALS LLC]42 package rows20241215_4e1621cb-5c72-4ebb-a331-e96005dffbc0.zip